Journal article

Type II fatty acid synthesis is essential only for malaria parasite late liver stage development

Ashley M Vaughan, Matthew T O'Neill, Alice S Tarun, Nelly Camargo, Thuan M Phuong, Ahmed SI Aly, Alan F Cowman, Stefan HI Kappe

Cellular Microbiology | WILEY | Published : 2009

University of Melbourne Researchers


Funding Acknowledgements

This work was partially funded by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative. Potential conflicts of interest: S.H.I.K. is an inventor listed on US Patent No. 7,22,179, US Patent no. 7,261,884 and international patent application PCT/US2004/043023, each titled 'Live Genetically Attenuated Malaria Vaccine'. We would like to thank the Walter Reed Army Institute of Research for providing us with the NF54 P. falciparum parasites and Lawrence W. Bergman, Drexel University College of Medicine, Philadelphia, Pennsylvania for use of the rabbit polyclonal antibody to P. yoelii MSP1.